Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
View Patent ↗An implantable expandable medical device in which selected regions of the device are in a martensite phase and selected regions are in an austenite phase. The martensitic regions exhibit pseudoplastic behavior in vivo and may be deformed without recovery under in vivo body conditions. In contrast the austenitic regions exhibit superelastic behavior in vivo and will recover their pre-programmed configuration upon deformation or release of an applied strain.
1. An implantable, geometrically expandable, generally tubular, nickel-titanium medical device, comprising:
a. a plurality of circumferentially self-expansible members interconnected by a plurality of first hinge regions;
b. a plurality of interconnecting members interconnecting adjacent pairs of circumferentially self-expansible members, the plurality of interconnecting members having a first portion and a second portion comprising a greater part of the interconnecting member than a second hinge member disposed between the first and second portions, the first and second portions being oblique to the second hinge member at a point immediately adjacent to a junction between the second hinge member and either the first or the second portions, wherein the majority of the second hinge member is martensitic in vivo and the first and second portions are austensitic in vivo;
c. where each of the plurality of first hinge regions permits circumferential expansion of the device by at least one of elastic or pseudoelastic deformation in vivo; and
d. where each of the plurality of second hinge regions is capable of deforming by at least one of plastic or pseudoplastic deformation along a longitudinal axis of the device in vivo under the influence of a flexing load.
2. The device according to claim 1 , wherein each of the plurality of circumferentially self-expansible members further comprises a ring member having of a plurality of generally linear structural members interconnected at opposing ends thereof by one of the plurality of first hinge regions.
3. The device according to claim 2 , wherein each of the plurality of generally linear structural members and each of the plurality of first hinge regions further comprise a nickel-titanium alloy in a sufficiently austenite phase to behave pseudoelastically in vivo.
4. The device according to claim 3 , wherein each of the plurality of interconnecting members have regions thereof that are in a sufficiently austenitic phase to operate in at least one of an elastic or pseudoelastic manner in vivo.
5. The device according to claim 1 , wherein each of the plurality of circumferentially self-expansible members further comprises a material selected from the group consisting of biocompatible metals, metal alloys and pseudometals that are capable of behaving elastically or pseudoelastically in vivo.
6. The device according to claim 5 , wherein each of the plurality of interconnecting members further comprises a material selected from the group consisting of biocompatible metals, metal alloys and pseudometals that are capable of behaving plastically or pseudoplastically in vivo.
7. An implantable, expandable medical device comprising:
a. a plurality of circumferential ring members, each having a plurality of generally linear members interconnected by a plurality of first hinge members; and
b. a plurality of interconnecting members each having at least one second hinge member disposed between non-hinge regions, wherein the interconnecting members interconnect adjacent pairs of the circumferential ring members;
wherein the non-hinge regions are oblique to the second hinge member at a point immediately adjacent to a junction between the second hinge member and either of the non-hinge regions, wherein a majority of at least some of the second hinge members is martensitic, while the non-hinge regions of the interconnecting members are generally austenitic, wherein the second hinge members are substantially non-collinear with the non-hinge regions of the interconnecting members when the device is in an expanded state, and wherein the non-hinge regions comprise a greater part of the interconnecting members than the second hinge members.
8. The device according to claim 7 , wherein each of the plurality of interconnecting members further comprises a material having a martensite-austenite phase gradient therein.
9. The device according to claim 7 , wherein each of the plurality of circumferential ring members further comprises a material selected from the group consisting of elastically or pseudoelastically deformable biocompatible metals, metal alloys and pseudometals.
10. The device according to claim 7 , wherein each of the plurality of interconnecting members further are in a sufficiently austenite phase to behave pseudoelastically in vivo.
11. The device according to claim 7 , wherein each of the plurality of interconnecting members further comprise a shape memory alloy in a sufficiently martensite phase to behave pseudoplastically in vivo.
12. The device according to claim 7 , wherein each of the plurality of interconnecting members further comprises a material selected from the group consisting of plastically or pseudoplastically deformable biocompatible metals, metal alloys and pseudometals.
13. An implantable medical device, comprising:
a generally tubular member comprising a plurality of circumferential ring members each having a plurality of strut members interconnected by first hinge members; and
a plurality of interconnecting members configured to connect adjacent pairs of circumferential ring members, each of the interconnecting members having a first portion, a second portion, and a second hinge member disposed between the first and second portions, the first and second portions being oblique to the second hinge member at a point immediately adjacent to a junction between the second hinge member and either the first or the second portions;
where the plurality of strut members, the first hinge members, and the first and second portions of the plurality of interconnecting members have an austenitic phase in vivo to permit at least one of elastic or pseudoelastic circumferential expansion in vivo;
where a majority of at least some of the second hinge members is martensitic to permit plastic or pseudoplastic deformation of the tube member along the longitudinal axis of the device in vivo and the first portion and the second portion are austensitic and comprise a greater part of the interconnecting members than the second hinge members; and
where the second hinge members are substantially non-collinear with other regions of the interconnecting members when the second hinge members behave plastically or pseudoplastically under in vivo conditions.
14. The implantable medical device according to claim 13 , wherein the generally tubular member further comprises a nickel-titanium alloy.
15. The implantable medical device according to claim 13 , wherein the first hinge regions further comprise regions that are sufficiently austenitic under in vivo conditions to allow at least about 90% recovery of an unstrained configuration of the device.
16. The implantable medical device according to claim 13 , wherein the second hinge regions further have a higher transition temperature than the remainder of the generally tubular member.
17. The implantable medical device according to claim 13 , wherein at least some of the strut members, at least some of the first hinge members, and at least some of the interconnecting members comprise a material selected from the group consisting of biocompatible metals, metal alloys and pseudometals that are capable of behaving elastically or pseudoelastically in vivo.
18. The implantable medical device according to claim 13 , wherein at least some of the plurality of strut members, at least some of the first hinge members, and at least some of the interconnecting members comprise a material selected from the group consisting of biocompatible metals, metal alloys and pseudometals that are capable of behaving plastically or pseudoplastically in vivo.